Association of hemostatic variables with MRI-detected cerebral abnormalities: The Atherosclerosis Risk in Communities Study

Neuroepidemiology

Volumn 20, Issue 2, 2001, Pages 96-104

  Knuiman, Matthew W ^a   Folsom, Aaron R ^b   Chambless, Lloyd E ^c   Liao, Duanping ^d   Wu, Kenneth K ^e  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF MINNESOTA   (United States)

^c IL   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Atherosclerosis Risk in Communities Study; Cerebral infarction; Cerebrovascular disease; Fibrinogen; Hemostasis; Magnetic resonance imaging; White matter disease

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; PROTEIN C; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; ATHEROSCLEROSIS; BRAIN INFARCTION; BRAIN ISCHEMIA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL THROMBOPLASTIN TIME; RISK FACTOR; STROKE; THROMBOCYTE COUNT; WHITE MATTER;

EID: 0035000357     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054767     Document Type: Article

References (37)

1. Meade TW: Haemostatic function and arterial disease. Br Med Bull 1994;50:755-775.
2. Catto AJ, Grant PJ: Risk factors for cerebro-vascular disease and the role of coagulation and fibrinolysis. Blood Coagul Fibrinolysis 1995;6: 497-510.
3. de la Serna G: Fibrinogen: A new major risk factor for cardiovascular disease. J Fam Pract 1994;39:468-477.
4. Lip GYH: Fibrinogen and cardiovascular disorders. QJM 1995;88:155-165.
5. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-505.
6. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB: Fibrinogen and risk of cardiovascular disease: The Framingham Study. JAMA 1987; 258:1183-1186.
7. Smith FB, Lee AJ, Fowkes FGR, Price JF, Rumley A, Lowe GDO: Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1997;17:3312-3325.
8. Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ, Rasmussen ML, Wu KK: Prospective study of markers of hemostatic function with risk of ischemic stroke. Circulation 1999;100:736-742.
9. Tracy RP, Arnold AM, Ettinger W, Fried L, Meilahn E, Savage P: The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: Results from the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999;19:1776-1783.
10. Bronner LL, Kantor DS, Manson JE: Primary prevention of stroke. N Engl J Med 1995;333: 1392-1400.
11. The ARIC Investigators: The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. Am J Epidemiol 1989;129: 687-702.
12. Sharrett AR: The Atherosclerosis Risk in Communities (ARIC) Study: Introduction and objectives of the hemostasis component. Ann Epidemiol 1992;2:467-469.
13. Folsom AR, Conlan MG, Davis CE, Wu KK: Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Ann Epidemiol 1992;2:481-494.
14. Folsom AR, Wu KK, Shahar E, Davis CE: Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler Thromb 1993;13:1829-1836.
15. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, Wu KK: Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993;70: 380-385.
16. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Wu KK: Correlation of plasma protein C levels with cardiovascular risk factors in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993;70:762-767.
17. Conlan MG, Folsom AR, Finch A, Davis CE, Marcucci G, Sorlie P, Wu KK: Antithrombin III: Associations with age, race, sex and cardiovascular disease risk factors. Thromb Haemost 1994;72:551-556.
18. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE: Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997;96: 1102-1108.
19. Bryan RN, Wells SW, Miller TJ, Elster AD, Jungreis CA, Poirier VC, Lind BK, Manolio TA: Infarctlike lesions in the brain: Prevalence and anatomic characteristics at MR imaging of the elderly - Data from the Cardiovascular Health Study. Radiology 1997;202:47-54.
20. Papp AC, Hatzakis H, Bracey A, Wu KK: ARIC hemostasis study. I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 1989;61:15-19.
21. Wu KK, Papp AC, Patsch W, Rock R, Eckfeldt J, Sharrett R: ARIC hemostasis study. II. Organizational plan and feasibility study. Thromb Haemost 1990;64:521-525.
22. Bond MG, Barnes RW, Riley WA, Wilmoth SK, Chambless LE, Howard G, Owens B: High-resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities (ARIC) Study. J Neuroimag 1991;1: 68-73.
23. Riley WA, Barnes RW, Bond MG, Evans G, Chambless LE, Heiss G: High-resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities (ARIC) Study. J Neuroimag 1991;1:168-172.
24. Chambless LE, McMahon R, Wu K, Folsom A, Finch A, Shen YL: Short-term intraindividual variability in hemostasis factors: The ARIC Study. Ann Epidemiol 1992;2:723-733.
25. Manolio TA, Kronmal RA, Burke GL, Poirier V, O'Leary DH, Gardin JM, Fried LP, Steinberg EP, Bryan RN: Magnetic resonance abnormalities and cardiovascular disease in older adults - The Cardiovascular Health Study. Stroke 1994;25:318-327.
26. Bryan RN, Manolio TA, Schertz LD, Jungreis C, Poirier VC, Elster AD, Kronmal RA: A method for using MR to evaluate the effects of cardiovascular disease on the brain: The Cardiovascular Health Study. AJNR Am J Neuroradiol 1994;15:1625-1633.
27. Liao D, Cooper L, Cai J, Toole J, Bryan N, Burke G, Shahar E, Nieto J, Mosley T, Heiss G: The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: The ARIC Study. Neuroepidemiology 1997; 16:149-162.
28. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, Wiley & Sons, 1989.
29. Danesh J, Collins R, Appleby P, Peto R: Association of fibrinogen, C-reactivc protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 1998;279:1477-1482.
30. Meade TW, Ruddock V, Stirling Y, Chakrabarti RR, Miller GJ: Fibrinolytic activity, clotting factors, and long-term incidence of ischacmic heart disease in the Northwick Park Heart Study. Lancet 1993;324:1076-1079.
31. Ruggeri ZM, Ware J: The structure and function of von Willebrand factor. Thromb Haemost 1992;67:594-599.
32. Blann A: von Willebrand factor and the endothelium in vascular disease. Br J Biomed Sci 1993;50:125-134.
33. Cortellaro M, Boschetti C, Cofrancesco E, Zanussi C, Catalano M, de Gaetano G, Gabrielli L, Lombardi B, Specchia G, Tavazzi L, Tremoli TE, della Vilpe A, Polli E: The PLAT Study: Hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients: Principal results. Arterioscler Thromb 1992;12:1063-1070.
34. Bamford J, Sandercock P, Jones L, Warlow C: The natural history of lacunar infarction: The Oxfordshire Community Stroke project. Stroke 1987;18:545-551.
35. Meyer JS, Kawamura J, Terayama Y: White matter lesions in the elderly. J Neurol Sci 1992; 110:1-7.
36. Tomimoto H, Akiguchi I, Wakita H, Osaki A, Hayashi M, Yamamoto Y: Coagulation activation in patients with Binswanger disease. Arch Neurol 1999;56:1104-1108.
37. Golomb J, Kluger A, Gianutsos J, Ferris SH, de Leon MJ, George AE: Nonspecific leukoencephalopathy associated with aging. Neuroimaging Clin North Am 1995;5:33-44.